Type 1 diabetes is characterized by a mononuclear infiltration, common
ly called <<insulitis>>. The cells that constitute the insulitis are m
ainly monocytes that are recruited from extraislet areas and arrive at
the islet site via the vascular system. Infiltrating cells must then
pass across the endothelia to gain access to the islet parenchyma. The
anatomy and physiology of the islet microvasculature shows that islet
B cells are firstly perfused and influence both endocrine non-B islet
cells and peri-insular exocrine cells. The low dose streptozocin (LDS
) treatment is able to induce, other than a monocyte/macrophage recrui
tment and activation, islet vascular alterations, mainly at the level
of post-capillary venules encircling the islets of Langerhans and a co
ncomitant fall in Superoxide-dismutase (SOD) (the first cellular defen
ce against free radicals) activity. These findings, together with the
increase in vascular permeability and the morphological evidence of ar
eas of oedema formation within the islets, have raised the interest in
the <<microvascular>> approach to this disease. Actually the reductio
n in B-cell perfusion and the concomitant attack by phagocytes with a
fall in SOD activity should be considered as events that are linked to
each other. On the other hand both macrophages and endothelia are abl
e to produce free radicals and, in particular, nitric oxide. This conf
irms that the islet vascular system seems to be involved in early insu
litis and B-cell lysis.